Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 2,140 | 415 | 160 | 218 | 3,275 |
| Gross Profit | 2,140 | 415 | 160 | 218 | 3,290 |
| Operating Expenses | 4,705 | 4,295 | 3,695 | 3,919 | 5,220 |
| Operating Income | -2,565 | -3,880 | -3,534 | -3,701 | -1,945 |
| Interest Expense | 180 | 0 | 0 | 4 | 2,260 |
| Other Income | 8 | -2 | 5 | 1 | 35 |
| Pre-tax Income | -2,738 | -3,882 | -3,530 | -3,705 | -4,170 |
| Income Tax | 163 | 40 | N/A | N/A | N/A |
| Net Income Continuous | -2,902 | -3,922 | -3,530 | -3,705 | -4,166 |
| Net Income | $-2,902 | $-3,922 | $-3,530 | $-3,705 | $-4,166 |
| EPS Basic Total Ops | -4.80 | -8.00 | -9.60 | -10.40 | -16.80 |
| EPS Basic Continuous Ops | -4.92 | -8.07 | -9.60 | -10.12 | -16.72 |
| EPS Diluted Total Ops | -4.80 | -8.00 | -9.60 | -10.40 | -16.80 |
| EPS Diluted Continuous Ops | -4.92 | -8.07 | -9.60 | -10.12 | -16.72 |
| EBITDA(a) | $-2,492 | $-3,800 | $-3,458 | $-3,623 | $-1,864 |